SI-BONE To Present at BofA Securities 2022 Healthcare Conference

Rhea-AI Summary

SI-BONE, Inc. (Nasdaq: SIBN) will participate in the 2022 Bank of America Healthcare Conference in Las Vegas, hosting a fireside chat presentation on May 11, 2022, at 12:40 PM PT / 3:40 PM ET. A live webcast and archived recording will be accessible on the company's website for 90 days post-event.

SI-BONE specializes in surgical treatments for musculoskeletal disorders, particularly with its iFuse Implant System, which addresses SI joint pain, responsible for 15%-30% of chronic low back pain. More than 65,000 procedures have been performed using this system.

SANTA CLARA, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2022 Bank of America Healthcare Conference in Las Vegas. Management will be hosting a fireside chat presentation on Wednesday, May 11^th, 2022, at 12:40 p.m. Pacific Time / 3:40 p.m. Eastern Time.

A live webcast of each event, as well as an archived recording will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcasts will be archived and available for replay for at least 90 days after the event.

About SI-BONE, Inc.

SI-BONE (NASDAQ: SIBN) is a global leader in technology for surgical treatment of musculoskeletal disorders of the sacropelvic anatomy. In 2009, SI-BONE introduced the iFuse Implant System for minimally invasive surgery of the SI joint, shown to be a source of pain in 15% to 30% of chronic low back pain. Since then, more than 2,700 surgeons have performed a combined total of more than 65,000 SI joint fusion procedures. A unique body of evidence, supporting the iFuse Implant System, including two RCT’s and over 100 peer reviewed publications, has enabled multiple government and private insurance payors to establish coverage of the SI joint fusion procedure exclusively when performed with the iFuse Implant System. SI-BONE is leveraging its market leadership position, supported by this proprietary reimbursement advantage, to commercialize other devices intended for surgical treatment of related aspects of the human anatomy. For more information or to join our team, please visit us at www.si-bone.com.

For additional information on the company or the products including risks and benefits, please visit www.si-bone.com.

SI-BONE and iFuse Implant System are registered trademarks of SI-BONE, Inc. ©2022 SI-BONE, Inc. All Rights Reserved.

Investor Contact:

Matt Bacso, CFA
investors@SI-BONE.com

Media Contact:
Joe Powers
jpowers@si-bone.com

FAQ

What date will SI-BONE present at the 2022 Bank of America Healthcare Conference?

SI-BONE will present on May 11, 2022.

What is the purpose of SI-BONE's participation in the Bank of America Healthcare Conference?

SI-BONE aims to discuss its medical innovations and market leadership in musculoskeletal disorders.

Where can I watch the webcast of SI-BONE's presentation?

The webcast will be available on the 'Investors' section of SI-BONE's website.

What is the iFuse Implant System by SI-BONE?

The iFuse Implant System is designed for minimally invasive surgery of the SI joint, addressing pain in chronic low back pain patients.

How many SI joint fusion procedures have been performed using the iFuse Implant System?

More than 65,000 SI joint fusion procedures have been performed with the iFuse Implant System.